Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BRAF inhibitor-induced panniculitis in patients treated for stage IV metastatic melanoma: a case series.

Skeletal radiology - 1 Jun 2021

Bartlett David J, Erie Andrew J, Baffour Francis I, Broski Stephen M, Glazebrook Katrina N

Abstract excerpt

BRAF and MEK inhibitor combination therapy is the standard treatment for patients with BRAF V600E mutant metastatic melanoma. Neutrophilic panniculitis is a known rare complication of BRAF inhibitor therapy and can act as a potential mimic of melanoma metastases on 18F-FDG PET/CT. In this case series, we present three cases of BRAF inhibitor-induced panniculitis in patients being treated for BRAF-mutant...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Fluorodeoxyglucose F18
Share to Melanoma
Share to Mutation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Panniculitis

Share to Positron Emission Tomography Computed Tomography

Share to Proto-Oncogene Proteins B-raf

Share to Skin Neoplasms

Source

Identifiers

PMID: 33165713
DOI: 10.1007/s00256-020-03665-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BRAF inhibitor-induced panniculitis in patients treated for stage IV metastatic melanoma: a case series.PMID 33165713Read ↗

Research letter: BRAF-inhibitor induced panniculitis - A systematic review.Semantic proximity Read ↗

BRAF inhibition and the spectrum of granulomatous reactions.Semantic proximity Read ↗

[Panniculitis in patients treated with BRAF/MEK inhibitors: Presentation of 4 new cases].Semantic proximity Read ↗

Paraneoplastic leukemoid reaction in a patient with BRAF V600E-mutated metastatic malignant melanoma.Semantic proximity Read ↗

Novel cutaneous effects of combination chemotherapy with BRAF and MEK inhibitors: a report of two cases.Semantic proximity Read ↗

Case Report: Immune-Related Toxicity During Adjuvant Treatment With BRAF Plus MEK Inhibitors in a Melanoma Patient.Semantic proximity Read ↗

BRAF Mutant Pulmonary Melanoma with Brain Metastasis in a Young Female: A Case ReportSemantic proximity Read ↗

Hemorrhage of liver and bone metastases as a result of rapid response to dual BRAF/MEK inhibition in metastatic melanoma: a case report.Semantic proximity Read ↗

A Rare Case of BRAF-mutated Metastatic Pleomorphic Xanthoastrocytoma Patient who Developed Radiodermatitis After Receiving Anti-BRAF Treatment.Semantic proximity Read ↗

Case report: acute tumour lysis syndrome following encorafenib and binimetinib for v600E metastatic melanoma with large intra-abdominal mass.Semantic proximity Read ↗

Panniculitis during avapritinib therapy for gastrointestinal stromal tumour.Semantic proximity Read ↗

Granuloma Annulare Secondary to Vemurafenib Therapy for Lung Adenocarcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.